GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyclacel Pharmaceuticals Inc (NAS:CYCCP.PFD) » Definitions » Other Liabilities for Insurance Companies

Cyclacel Pharmaceuticals (Cyclacel Pharmaceuticals) Other Liabilities for Insurance Companies


View and export this data going back to 2005. Start your Free Trial

What is Cyclacel Pharmaceuticals Other Liabilities for Insurance Companies?

Other Liabilities for Insurance Companies only applies to insurance companies.


Cyclacel Pharmaceuticals (Cyclacel Pharmaceuticals) Business Description

Industry
Traded in Other Exchanges
Address
200 Connell Drive, Suite 1500, Berkeley Heights, NJ, USA, 07922
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.